Elucid Revenue and Competitors
Estimated Revenue & Valuation
- Elucid's estimated annual revenue is currently $33.6M per year.
- Elucid's estimated revenue per employee is $251,000
- Elucid's total funding is $145M.
Employee Data
- Elucid has 134 Employees.
- Elucid grew their employee count by 26% last year.
Elucid's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO, Board Director | Reveal Email/Phone |
2 | Chief Scientific Advisor | Reveal Email/Phone |
3 | SVP, Product | Reveal Email/Phone |
4 | SVP Marketing | Reveal Email/Phone |
5 | Director Training and Quality Production | Reveal Email/Phone |
6 | Product Manager | Reveal Email/Phone |
7 | Analysis Quality Manager | Reveal Email/Phone |
8 | Product Manager | Reveal Email/Phone |
9 | Clinical Validation Engineer | Reveal Email/Phone |
10 | Technical Lead - Feature Team | Reveal Email/Phone |
Elucid Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11M | 44 | 13% | N/A | N/A |
#2 | $11M | 44 | 29% | N/A | N/A |
#3 | $4.3M | 17 | 0% | N/A | N/A |
#4 | $3.8M | 15 | -29% | N/A | N/A |
#5 | $5630M | 9122 | -11% | $450M | N/A |
#6 | $4.3M | 17 | 0% | N/A | N/A |
#7 | $4M | 16 | -72% | $23.5M | N/A |
#8 | $44.4M | 177 | 9% | N/A | N/A |
#9 | $45.7M | 182 | 0% | N/A | N/A |
#10 | $15M | 79 | 8% | $105.2M | N/A |
What Is Elucid?
Elucid Bioimaging is a medical technology company leveraging machine intelligence to improve the accuracy, experience, and cost-effectiveness of vascular diagnostic imaging. Its groundbreaking product, vascuCAP®, is the first FDA-cleared & CE-marked, histology-validated, non-invasive image analysis software for evaluating CTAs to provide multi-dimensional visualization, structural measurements, & plaque composition to inform risk of event (heart attack or stroke) and personalized treatment selection. vascuCAP® is in use by cardiologists, vascular surgeons, radiologists, and neurologists across the US and EU at health systems, clinics, and research institutes. vascuCAP® has applications for coronary, carotid, and peripheral arteries. In addition, Elucid also offers quantifying imaging services to evaluate the severity of vascular disease, in particular, atherosclerosis, and assess longitudinal therapeutic response to investigative therapeutic agents to vascular disease
keywords:N/A
$145M
Total Funding
134
Number of Employees
$33.6M
Revenue (est)
26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Elucid News
Elucid Magazine is an active force in the fashion community. We unite the city's leading visionaries and artists under one editorial roof.
ELUCID has a new solo LP on the way too, called I Told Bessie, and he'll celebrate it with a release show on June 16 at Mercury Lounge,...
... bands play NYC), and Soul Glo will come to NYC to open Armand Hammer member ELUCID's album release show on June 16 at Mercury Lounge.
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $20.1M | 134 | 4% | N/A |
#2 | $33.5M | 134 | -1% | N/A |
#3 | $18.8M | 134 | 15% | N/A |
#4 | $15M | 134 | -7% | N/A |
#5 | $15M | 134 | 2% | N/A |